EarningsQ1 2025 Earnings Report

Nektar Therapeutics (NKTR) Q1 2025 Earnings Report

0 Followers

MX:NKTR Q1 2025 EPS Results

Actual EPS-$66.21

Consensus EPS-$47.15

Beat/MissMissed by -$19.05

One Year Ago EPS-$52.41

Actual Revenue$192.37M

Expected Revenue$282.36M

Beat/MissMissed by -$89.99M

YoY Revenue Growth-51.66%

QuarterQ1 2025

Date05/08/2025

TimeAfter Close

Conference CallThursday, May 8, 2025

MX:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NKTR Q1 2025 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-37.94 / -	-34.391	―
Aug 13, 2026	2026 (Q2)	-36.25 / -22.62	-54.254	58.31% (+31.63)
May 07, 2026	2026 (Q1)	-29.09 / -33.47	-66.208	49.44% (+32.74)
Mar 12, 2026	2025 (Q4)	-45.50 / -32.74	8.276	-495.56% (-41.01)
Nov 06, 2025	2025 (Q3)	-49.38 / -34.39	-49.656	30.74% (+15.26)
Aug 07, 2025	2025 (Q2)	-55.69 / -54.25	-68.967	21.33% (+14.71)
May 08, 2025	2025 (Q1)	-47.15 / -66.21	-52.415	-26.32% (-13.79)
Mar 12, 2025	2024 (Q4)	-37.41 / 8.28	-60.691	113.64% (+68.97)
Nov 07, 2024	2024 (Q3)	-54.90 / -49.66	-66.208	25.00% (+16.55)
Aug 08, 2024	2024 (Q2)	-51.04 / -68.97	-74.484	7.41% (+5.52)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed